A Proximity-incentive Strategy for Cervical Cancer Screening

NACompletedINTERVENTIONAL
Enrollment

656

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

July 25, 2023

Study Completion Date

July 25, 2024

Conditions
Cervical CancerUterine Cervical DiseaseHuman Papilloma Virus
Interventions
BEHAVIORAL

Proximity-incentive strategy based on vaginal self-sampling for women 50 to 65 years who do not participate to cervical cancer screening

"* Direct offer of a vaginal self-sampling kit with information to perform at home and send back to the laboratory for HR-HPV testing~* The psychosocial determinants involved in decision-making process and compliance to cervical cancer screening will be collected from open questionnaires and by semi-directive phone interviews~* Control ; Receive reminder to send the self-sample to the laboratory : After 3 and 6 months without return, women receive a remind letter to send the vaginal self-sample to the laboratory. We call return the receipt of the vaginal self-sample at the laboratory.~* Control ; Receive reminder to perform cervical smear in case of positive HR-HPV test : In case of a positive HR-HPV test, women are asked to perform a control cervical smear. After 3, 6 months and 12 months without return, women and their health-care professional will receive a remind letter or a call to perform a cervical smear for control. We call return the performance of a pap smear."

Trial Locations (2)

34295

Arnaud de Villeneuve Hospital, clinical trials Department, Montpellier

Unknown

Mammobile Hérault, Montpellier

All Listed Sponsors
collaborator

Paul Valérie University Montpellier

UNKNOWN

collaborator

Regional Center for Cancer Screening (CRCDC) - Region of Occitanie - Department of Herault

UNKNOWN

collaborator

Regional Center for Cancer Screening (CRCDC) - Region of Occitanie - Department of Aude

UNKNOWN

collaborator

Association for Breast Cancer Screening - Department of Herault (AMHDCS)

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT04716127 - A Proximity-incentive Strategy for Cervical Cancer Screening | Biotech Hunter | Biotech Hunter